Cargando…

Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report

BACKGROUND: The screening for intestinal carriage of vancomycin-resistant Enterococcus spp. (VRE) among high risk patients in the Balkan region and molecular epidemiology of VRE is insufficiently investigated, yet it could be of key importance in infection control. The aim of this study was to provi...

Descripción completa

Detalles Bibliográficos
Autores principales: Janjusevic, Ana, Markovic Denic, Ljiljana, Minic, Rajna, Grgurevic, Anita, Cirkovic, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981873/
https://www.ncbi.nlm.nih.gov/pubmed/33743726
http://dx.doi.org/10.1186/s12941-021-00423-0
_version_ 1783667602536529920
author Janjusevic, Ana
Markovic Denic, Ljiljana
Minic, Rajna
Grgurevic, Anita
Cirkovic, Ivana
author_facet Janjusevic, Ana
Markovic Denic, Ljiljana
Minic, Rajna
Grgurevic, Anita
Cirkovic, Ivana
author_sort Janjusevic, Ana
collection PubMed
description BACKGROUND: The screening for intestinal carriage of vancomycin-resistant Enterococcus spp. (VRE) among high risk patients in the Balkan region and molecular epidemiology of VRE is insufficiently investigated, yet it could be of key importance in infection control. The aim of this study was to provide baseline data on VRE intestinal carriage among high-risk patients in Serbian university hospitals, to determine the phenotypic/genotypic profiles of the isolated VRE, to obtain knowledge of local resistance patterns and bridge the gaps in current VRE surveillance. METHODS: The VRE reservoir was investigated using stool samples from 268 inpatients. Characterization of isolated VRE stains consisted of BD Phoenix system, genotypic identification, glycopeptide and quinupristin–dalfopristin (Q–D) resistance probing, virulence gene (esp, hyl, efaA, asa1, gelE, cpd) detection and MLVA. Biofilm formation was evaluated by the microtiter plate method. RESULTS: VRE carriage prevalence among at-risk patients was 28.7%. All VRE strains were vanA positive multidrug-resistant Enterococcus faecium (VRfm), harboring ermB-1 (38.9%), esp (84%), efaA (71.2%), hyl (54.5%), asa1 (23.4%), gelE and cpd (11.6%) each. Ability of biofilm production was detected in 20.8%. Genetic relatedness of the isolates revealed 13 clusters, heterogeneous picture and 25 unique MTs profiles. CONCLUSION: The obtained prevalence of VRE intestinal carriage among high-risk inpatients in Serbia is higher than the European average, with high percentage of multidrug resistance. The emergence of resistance to Q–D is of particular concern. Close monitoring of pattern of resistance and strict adherence to specific guidelines are urgently needed in Serbia.
format Online
Article
Text
id pubmed-7981873
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79818732021-03-22 Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report Janjusevic, Ana Markovic Denic, Ljiljana Minic, Rajna Grgurevic, Anita Cirkovic, Ivana Ann Clin Microbiol Antimicrob Research BACKGROUND: The screening for intestinal carriage of vancomycin-resistant Enterococcus spp. (VRE) among high risk patients in the Balkan region and molecular epidemiology of VRE is insufficiently investigated, yet it could be of key importance in infection control. The aim of this study was to provide baseline data on VRE intestinal carriage among high-risk patients in Serbian university hospitals, to determine the phenotypic/genotypic profiles of the isolated VRE, to obtain knowledge of local resistance patterns and bridge the gaps in current VRE surveillance. METHODS: The VRE reservoir was investigated using stool samples from 268 inpatients. Characterization of isolated VRE stains consisted of BD Phoenix system, genotypic identification, glycopeptide and quinupristin–dalfopristin (Q–D) resistance probing, virulence gene (esp, hyl, efaA, asa1, gelE, cpd) detection and MLVA. Biofilm formation was evaluated by the microtiter plate method. RESULTS: VRE carriage prevalence among at-risk patients was 28.7%. All VRE strains were vanA positive multidrug-resistant Enterococcus faecium (VRfm), harboring ermB-1 (38.9%), esp (84%), efaA (71.2%), hyl (54.5%), asa1 (23.4%), gelE and cpd (11.6%) each. Ability of biofilm production was detected in 20.8%. Genetic relatedness of the isolates revealed 13 clusters, heterogeneous picture and 25 unique MTs profiles. CONCLUSION: The obtained prevalence of VRE intestinal carriage among high-risk inpatients in Serbia is higher than the European average, with high percentage of multidrug resistance. The emergence of resistance to Q–D is of particular concern. Close monitoring of pattern of resistance and strict adherence to specific guidelines are urgently needed in Serbia. BioMed Central 2021-03-20 /pmc/articles/PMC7981873/ /pubmed/33743726 http://dx.doi.org/10.1186/s12941-021-00423-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Janjusevic, Ana
Markovic Denic, Ljiljana
Minic, Rajna
Grgurevic, Anita
Cirkovic, Ivana
Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report
title Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report
title_full Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report
title_fullStr Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report
title_full_unstemmed Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report
title_short Intestinal carriage of vancomycin‐resistant Enterococcus spp. among high‐risk patients in university hospitals in Serbia: first surveillance report
title_sort intestinal carriage of vancomycin‐resistant enterococcus spp. among high‐risk patients in university hospitals in serbia: first surveillance report
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981873/
https://www.ncbi.nlm.nih.gov/pubmed/33743726
http://dx.doi.org/10.1186/s12941-021-00423-0
work_keys_str_mv AT janjusevicana intestinalcarriageofvancomycinresistantenterococcussppamonghighriskpatientsinuniversityhospitalsinserbiafirstsurveillancereport
AT markovicdenicljiljana intestinalcarriageofvancomycinresistantenterococcussppamonghighriskpatientsinuniversityhospitalsinserbiafirstsurveillancereport
AT minicrajna intestinalcarriageofvancomycinresistantenterococcussppamonghighriskpatientsinuniversityhospitalsinserbiafirstsurveillancereport
AT grgurevicanita intestinalcarriageofvancomycinresistantenterococcussppamonghighriskpatientsinuniversityhospitalsinserbiafirstsurveillancereport
AT cirkovicivana intestinalcarriageofvancomycinresistantenterococcussppamonghighriskpatientsinuniversityhospitalsinserbiafirstsurveillancereport